Interestingly, as shown in RNA-seq analysis, VILMIR expression was reduced but not abolished in conditions with suppressed host IFN responses, such as after treatment with ruxolitinib, a JAK1/2 inhibitor, or after infection with IAV with an intact NS1 protein. Here, JAK1 is linked to infection.